Fina Biosolutions is located in Rockville, United States on 9430 Key W Ave. Fina Biosolutions is rated 3 out of 5 in the category biotechnology company in United States. Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel techniques to conjugate, purify, and manufacture conjugates using its proprietary chemistry to create complex conjugate vaccines. The technology is currently licensed by leading vaccine manufacturers in both Europe and Asia, including GlaxoSmithKline for marketed vaccines Synflorix™ Menitorix™, Nimenrix™, The Serum Institute of India Ltd., The Chengdu Institute of Biological Products and others. Fina Bosolutions also manufactures E. coli expressed CRM197 conjugate vaccine carrier portein. Fina BioSolutions also develops polymer based diagnostic reagents, amino dextran, and antibody dextran conjugates.
Company size
1-10 employees
Headquarters
Rockville, MARYLAND
Accessibility
Wheelchair-accessible entrance